4628
B.-T. Kim et al. / Tetrahedron 65 (2009) 4625–4628
J¼6.8 Hz, H-40), 2.54 (dd, 2H, J¼16.4, 5.6 Hz, Ha-10, 30), 2.46 (dd, 2H,
J¼16.4, 6.0 Hz, Hb-10, 30), 2.41 (m, 1H, H-20); 13C NMR (100 MHz,
chloroform (10 mLꢂ3). The combined extracts were evaporated in
vacuo to afford a dark red solid (40 mg, 34%): mp: 212–215 ꢁC
(decomposed). IR (film) 3450, 2253, 1620 (an extended quinone
CDCl3): d 160.98, 138.62, 116.84 (–CN), 106.73, 98.80, 55.20 (–OCH3),
39.04, 34.44, 21.11; MS [MþH]þ 245.12.
system) cmꢀ1; UV lmax (CHCl3) 271 (lg
3
¼2.99), 490 (2.01), 562
(0.70); 1H NMR (400 MHz, CDCl3):
d 8.42 (s, 2H, 2, 11-OH), 6.79 (s,
3.7. 2-(5,7-Dimethoxy-4-oxo-1,2,3,4-tetrahydronaphthalen-2-
yl)acetonitrile (7)
2H, H-5 and H-8), 4.23 (s, 6H, –OCH3ꢂ2), 4.15 (s, 6H, –OCH3ꢂ2),
3.99 (d, 2H, J¼16.8 Hz, Ha-20, Ha-200), 3.64 (d, 2H, J¼16.8 Hz, Hb-20,
Hb-200); 13C NMR (100 MHz, CDCl3):
d 174.74 (–CO–), 165.82, 165.24,
Zinc chloride (4.71 g, 34.58 mmol) was added to a solution of
dinitrile 6 (4.97 g, 20.34 mmol) in dry ether (100 mL). Hydrogen
chloride gas was passed through the mixture for 2 h. The ether
layer was discarded, and the resultant white solid was resolved
in water and refluxed for 2 h. After cooling, the mixture was
diluted with water and extracted with methylene chloride
(200 mLꢂ2). The combined organic layer was washed with satd
NaHCO3 (100 mLꢂ2), brine (100 mL), and water (100 mLꢂ2),
dried over Na2CO3, filtered, and evaporated in vacuo to produce
an off-white solid (4.45 g, 89%). Compound 7 was used without
further purification: mp: 122–123 ꢁC. IR (film): 2250, 1685,
151.39, 130.72, 127.66, 116.27 (–CN), 112.08, 108.43, 105.93, 94.47,
55.78, 56.42, 18.50; HRMS (ESI): m/z 513.1293 ([MþH]þ, calcd for
C28H21N2O8 513.1298). Method B. A neat solution of 1,2-naph-
thoquinone 8 (100 mg, 0.39 mmol) in trifluoroacetic acid (2 mL)
was stirred at 0 ꢁC for 4 h. The solution instantly turned green and
then dark blue over 30 min. The mixture was poured into ice-cold
water, and then the same purification process described in Method
A was applied to afford compound 9 (40 mg, 40%). The chloroform
layer after treatment with the solution of zinc acetate was con-
centrated in vacuo and subjected to flash column chromatography
to produce the starting material 8 (elution solvent system: CHCl3/
MeOH¼15:1 v/v, 15 mg, 15%) and an unknown material (10 mg).
Method C. A neat solution of 1,2-naphthoquinone 8 (124 mg,
0.48 mmol) in trifluoroacetic acid (2 mL) was stirred at 0 ꢁC for 4 h.
Aqueous HCl (6 N, 5 mL) was added to the resultant blue solution
and stirred for 2 days in air at the ambient temperature. The mix-
ture was poured into ice-cold water, and then the same purification
process described in Method A was applied to afford compound 9
(30 mg, 24%).
1600 cmꢀ1
;
1H NMR (400 MHz, CDCl3):
d
6.38 (d, 1H, J¼2.0 Hz,
H-6), 6.35 (d, 1H, J¼2.0 Hz, H-8), 3.89 (s, 3H, –OCH3), 3.86 (s, 3H,
–OCH3), 3.09 (dd, 1H, J¼15.6, 2.0 Hz, Ha-3), 2.86 (dd, 1H, J¼16.8,
10.8 Hz, Ha-1), 2.77 (dd, 1H, J¼16.8, 2.0 Hz, Hb-3), 2.54 (m, 1H, H-
2), 2.51 (dd, 1H, J¼19.2, 6.0 Hz, Ha-20), 2.44 (dd, 1H, J¼16.8,
10.8 Hz, Hb-1), 2.43 (dd, 1H, J¼16.8, 6.0 Hz, Hb-20); 13C NMR
(100 MHz, CDCl3):
d 193.10 (–CO–), 164.57, 162.88, 146.16, 117.63
(–CN), 115.56, 105.19, 97.79, 56.11, 55.60, 45.68, 36.43, 31.67,
23.11; HRMS (ESI): m/z 246.1030 ([MþH]þ, calcd for C14H16NO3
246.1052).
Acknowledgements
3.8. 2-(5,7-Dimethoxy-3,4-dioxo-3,4-dihydronaphthalen-2-
yl)acetonitrile (8)
This work was supported by the Grant of the Korean Ministry
of Education, Science and Technology in 2008 (The Regional
Core Research Program/Center for Healthcare Technology
Development).
Selenium dioxide (0.64 g, 5.75 mmol) was added to a solution of
bicyclic ketone 7 (0.47 g, 1.92 mmol) in glacial acetic acid (5 mL)
with stirring and the mixture was kept for 2 h at 70 ꢁC. The mixture
was poured into ice-water and extracted with methylene chloride
(50 mLꢂ2). The organic layer was washed with satd NaHCO3 and
water, dried over Na2CO3, filtered, and evaporated in vacuo. The
residue was applied to flash column chromatography (silica gel) to
afford 8 (0.38 g, 77%) as a brown-red solid: mp: 198–215 ꢁC
References and notes
1. (a) Weiss, U.; Nasini, G. Prog. Chem. Org. Nat. Prod. 1987, 52, 1–10; (b) Diwu, Z. J.;
Lown, J. W. Photochem. Photobiol. 1990, 52, 609–616.
2. Lown, J. W. Can. J. Chem. 1997, 75, 99–119.
3. (a) Diwu, Z. J. Photochem. Photobiol. 1995, 61, 529–539; (b) Falk, H. Angew.
Chem., Int. Ed. 1999, 38, 3116–3136.
4. (a) Kobayashi, E.; Nakano, H.; Morimoto, M.; Tamaoki, T. Biochem. Biophys. Res.
Commun. 1989, 159, 548–553; (b) Nishizuka, Y. Cancer 1989, 63, 1892–1903; (c)
Hinterding, K.; Alonso-Dı´az, D.; Waldmann, H. Angew. Chem., Int. Ed. 1998, 37,
689–749.
(decomposed). IR (film): 2250, 1666, 1649 cmꢀ1
(400 MHz, DMSO-d6): 7.56 (s, 1H, H-1), 6.90 (s, 1H, H-6), 6.71 (s,
1H, H-8), 3.92 (s, 3H, –OCH3), 3.90 (s, 3H, –OCH3), 3.67 (s, 2H, H-10);
13C NMR (100 MHz, DMSO-d6):
179.15 (–CO–), 174.16 (–CO–),
;
1H NMR
d
d
5. (a) Pollack, I. F.; Kawecki, S. J. Neurooncol. 1997, 31, 255–266; (b) Dubauskas, Z.;
Beck, T. P.; Chmura, S. J.; Kovar, D. A.; Kadkhodaian, M. M.; Shrivastav, M.;
Chung, T.; Stadler, W. M.; Rinker-Schaefer, C. W. Clin. Cancer Res. 1998, 4, 2391–
2398; (c) Zhu, D.-M.; Narla, R.-K.; Fang, W.-H.; Chia, N.-C.; Uckun, F. M. Clin.
Cancer Res. 1998, 4, 2967–2976; (d) Beck, T. P.; Kirsh, E. J.; Chmura, S. J.; Kovar,
D. A.; Chung, T.; Rinker-Schaefer, C. W.; Stadler, W. M. Urology 1999, 54, 573–
577.
166.17, 165.04, 142.10, 137.18, 130.09, 117.53 (–CN), 112.17, 110.77,
99.83, 56.35 (–OCH3), 56.22 (–OCH3), 17.55; HRMS (ESI): m/z
280.0588 ([MþNa]þ, calcd for C14H11NO4Na 280.0586).
3.9. 2,20-(2,11-Dihydroxy-4,6,7,9-tetramethoxy-3,10-dioxo-
3,10-dihydroperylene-1,12-diyl)diacetonitrile (1,12-
diacetonitrile-3,10-perylenequinone) (9)
6. Xing, M.-Z.; Zhang, X.-Z.; Sun, Z.-L.; Zhang, H. Y. J. Agric. Food Chem. 2003, 51,
7722–7724.
7. (a) Chao, C.; Zhang, P. Tetrahedron Lett. 1988, 29, 225–226; (b) Broka, C. A.
Tetrahedron Lett. 1991, 32, 859–862; (c) Coleman, R. S.; Grant, E. B. J. Org. Chem.
1991, 56, 1357–1359; (d) Diwu, Z.; Lown, J. W. Tetrahedron 1992, 48, 45–54; (e)
Zhao, C.; Zhang, X.-s; Zhang, P. Liebigs Ann. Chem. 1993, 35–41; (f) Liu, J.; Diwu,
Z.; Lown, J. W. Tetrahedron 1993, 49, 10785–10792; (g) Coleman, R. S.; Grant, E.
B. Tetrahedron Lett. 1993, 34, 2225–2228; (h) Coleman, R. S.; Grant, E. B. J. Am.
Chem. Soc. 1994, 116, 8795–8796; (i) Hauser, F. M.; Sengupta, D.; Corlett, S. A. J.
Org. Chem. 1994, 59, 1967–1969; (j) Liu, J.; Diwu, Z.; Lown, J. W. Synthesis 1995,
914–916; (k) Coleman, R. S.; Grant, E. B. J. Am. Chem. Soc. 1995, 117, 10889–
10904; (l) Merlic, C. A.; Aldrich, C. C.; Albaneze-Walker, J.; Saghatelian, A. J. Am.
Chem. Soc. 2000, 122, 3224–3225; (m) Merlic, C. A.; Aldrich, C. C.; Albaneze-
Walker, J.; Saghatelian, A.; Mammen, J. J. Org. Chem. 2001, 66, 1297–1309.
8. Hatch, R. P.; Shringarpure, J.; Weinreb, S. M. J. Org. Chem. 1978, 21, 4172–4177.
9. Viswanatha, V.; Rao, G. S. K. Tetrahedron Lett. 1974, 15, 247–248.
10. Yoshihara, T.; Shimanuki, T.; Araki, T.; Sakamura, S. Agric. Biol. Chem. 1975, 39,
1683–1684.
Method A.
A solution of 1,2-naphthoquinone 8 (170 mg,
0.66 mmol) and anhydrous ferric chloride (170 mg, 1.06 mmol) in
2 mL of anhydrous acetonitrile was stirred at room temperature for
3 h. The reaction mixture was poured into 3% aqueous HCl, and
then extracted with chloroform (50 mLꢂ3). The organic layer was
washed with water, dried over Na2CO3, filtered, and evaporated in
vacuo to afford a dark red solid. This solid was redissolved in
chloroform and then mixed with a 10% aqueous ethanol solution of
zinc acetate. This Zn-complex thus formed was washed with
chloroform (50 mLꢂ3), and then decomposed by 10% aqueous HCl
to release perylenequinone 9, which was again extracted with